The print · 8-K and call2026-11-04
Revenue—
est. —
EPS—
est. —
Guidance—read from the 8-K once filed
Vaxcyte, Inc. · Biotechnology
PCVX Vaxcyte, Inc. · Earnings
Reports 2026-11-04 · WedReaction day 11-05reported · reaction in progress
Get PCVX's results by email the night it reports
EPS and revenue vs. estimates, plus the first-day move. Free — unsubscribe in one click.
Report card
Done· 8-K + call· 11-04Breakdown
Key figures, the focus-point check, management quotes, the sector read and the grade are in the full view. Start 30-day free trial →
Reaction
Now· open / day / 5-day· 11-05 → day 5Reactionreaction not yet settled
After-hours move—no read yet
Open / day close— / —
5 days later—day 5 pending
Going in
Done· T-7 → T-1 freezeBefore the print · expectationsfrozen at T-1
No past prints on file yet.
Pricing going in · as of the 10-30 close
+9.8%Move over the last 20 sessionsLast 5 sessions +2.6%
—vs sector (XLV)XLV over the same window —
—Forward P/EConsensus: not available
What the record doesn't tell you
Which way does PCVX go on 11‑04?
- Model lean for 11-04, and the evidence behind it
- Move band, P10 – P90
- Last 8 prints, quarter by quarter
- Peers that already reported, and how they traded
Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →
Vaxcyte earnings review: what the record says
Vaxcyte (PCVX) reported earnings on Nov 4, 2026.
Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.